nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CYP2D6—Tamoxifen—pancreatic cancer	0.0554	0.203	CbGbCtD
Tiotropium—CYP2D6—Erlotinib—pancreatic cancer	0.0471	0.173	CbGbCtD
Tiotropium—CYP3A4—Tamoxifen—pancreatic cancer	0.0352	0.129	CbGbCtD
Tiotropium—CYP3A4—Erlotinib—pancreatic cancer	0.0299	0.11	CbGbCtD
Tiotropium—CYP3A4—Irinotecan—pancreatic cancer	0.027	0.0994	CbGbCtD
Tiotropium—CYP2D6—Doxorubicin—pancreatic cancer	0.0232	0.0854	CbGbCtD
Tiotropium—CYP3A4—Docetaxel—pancreatic cancer	0.0198	0.0728	CbGbCtD
Tiotropium—CYP3A4—Sunitinib—pancreatic cancer	0.0197	0.0725	CbGbCtD
Tiotropium—CYP3A4—Doxorubicin—pancreatic cancer	0.0148	0.0543	CbGbCtD
Tiotropium—Myalgia—Gemcitabine—pancreatic cancer	0.000984	0.00183	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000977	0.00182	CcSEcCtD
Tiotropium—Pruritus—Tamoxifen—pancreatic cancer	0.000971	0.00181	CcSEcCtD
Tiotropium—Oedema—Irinotecan—pancreatic cancer	0.000968	0.0018	CcSEcCtD
Tiotropium—Chest pain—Fluorouracil—pancreatic cancer	0.000968	0.0018	CcSEcCtD
Tiotropium—Myalgia—Fluorouracil—pancreatic cancer	0.000968	0.0018	CcSEcCtD
Tiotropium—Infection—Irinotecan—pancreatic cancer	0.000962	0.00179	CcSEcCtD
Tiotropium—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000961	0.00179	CcSEcCtD
Tiotropium—Pruritus—Erlotinib—pancreatic cancer	0.000961	0.00179	CcSEcCtD
Tiotropium—Shock—Irinotecan—pancreatic cancer	0.000953	0.00177	CcSEcCtD
Tiotropium—Nervous system disorder—Irinotecan—pancreatic cancer	0.00095	0.00177	CcSEcCtD
Tiotropium—Rhinitis—Docetaxel—pancreatic cancer	0.000945	0.00176	CcSEcCtD
Tiotropium—Oedema—Gemcitabine—pancreatic cancer	0.000943	0.00176	CcSEcCtD
Tiotropium—Infection—Gemcitabine—pancreatic cancer	0.000937	0.00175	CcSEcCtD
Tiotropium—Pharyngitis—Docetaxel—pancreatic cancer	0.000935	0.00174	CcSEcCtD
Tiotropium—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000931	0.00173	CcSEcCtD
Tiotropium—Abdominal pain—Sunitinib—pancreatic cancer	0.000929	0.00173	CcSEcCtD
Tiotropium—Oedema peripheral—Docetaxel—pancreatic cancer	0.000928	0.00173	CcSEcCtD
Tiotropium—Oedema—Fluorouracil—pancreatic cancer	0.000928	0.00173	CcSEcCtD
Tiotropium—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000926	0.00172	CcSEcCtD
Tiotropium—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000925	0.00172	CcSEcCtD
Tiotropium—Urethral disorder—Docetaxel—pancreatic cancer	0.000924	0.00172	CcSEcCtD
Tiotropium—Infection—Fluorouracil—pancreatic cancer	0.000921	0.00172	CcSEcCtD
Tiotropium—Pain in extremity—Epirubicin—pancreatic cancer	0.000919	0.00171	CcSEcCtD
Tiotropium—Skin disorder—Gemcitabine—pancreatic cancer	0.000916	0.00171	CcSEcCtD
Tiotropium—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00091	0.00169	CcSEcCtD
Tiotropium—Visual impairment—Docetaxel—pancreatic cancer	0.000908	0.00169	CcSEcCtD
Tiotropium—Dizziness—Tamoxifen—pancreatic cancer	0.000908	0.00169	CcSEcCtD
Tiotropium—Tachycardia—Fluorouracil—pancreatic cancer	0.000905	0.00169	CcSEcCtD
Tiotropium—Dizziness—Erlotinib—pancreatic cancer	0.000898	0.00167	CcSEcCtD
Tiotropium—Eye disorder—Docetaxel—pancreatic cancer	0.000881	0.00164	CcSEcCtD
Tiotropium—Insomnia—Irinotecan—pancreatic cancer	0.000876	0.00163	CcSEcCtD
Tiotropium—Vomiting—Tamoxifen—pancreatic cancer	0.000873	0.00163	CcSEcCtD
Tiotropium—Paraesthesia—Irinotecan—pancreatic cancer	0.00087	0.00162	CcSEcCtD
Tiotropium—Hypersensitivity—Sunitinib—pancreatic cancer	0.000866	0.00161	CcSEcCtD
Tiotropium—Rash—Tamoxifen—pancreatic cancer	0.000865	0.00161	CcSEcCtD
Tiotropium—Dermatitis—Tamoxifen—pancreatic cancer	0.000865	0.00161	CcSEcCtD
Tiotropium—Vomiting—Erlotinib—pancreatic cancer	0.000864	0.00161	CcSEcCtD
Tiotropium—Headache—Tamoxifen—pancreatic cancer	0.00086	0.0016	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000859	0.0016	CcSEcCtD
Tiotropium—Rash—Erlotinib—pancreatic cancer	0.000856	0.00159	CcSEcCtD
Tiotropium—Dermatitis—Erlotinib—pancreatic cancer	0.000856	0.00159	CcSEcCtD
Tiotropium—Angiopathy—Docetaxel—pancreatic cancer	0.000855	0.00159	CcSEcCtD
Tiotropium—Dehydration—Epirubicin—pancreatic cancer	0.000854	0.00159	CcSEcCtD
Tiotropium—Insomnia—Gemcitabine—pancreatic cancer	0.000853	0.00159	CcSEcCtD
Tiotropium—Dyspepsia—Irinotecan—pancreatic cancer	0.000852	0.00159	CcSEcCtD
Tiotropium—Immune system disorder—Docetaxel—pancreatic cancer	0.000851	0.00158	CcSEcCtD
Tiotropium—Headache—Erlotinib—pancreatic cancer	0.000851	0.00158	CcSEcCtD
Tiotropium—Pain in extremity—Doxorubicin—pancreatic cancer	0.00085	0.00158	CcSEcCtD
Tiotropium—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000849	0.00158	CcSEcCtD
Tiotropium—Paraesthesia—Gemcitabine—pancreatic cancer	0.000847	0.00158	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000845	0.00157	CcSEcCtD
Tiotropium—Dry skin—Epirubicin—pancreatic cancer	0.000842	0.00157	CcSEcCtD
Tiotropium—Arrhythmia—Docetaxel—pancreatic cancer	0.000842	0.00157	CcSEcCtD
Tiotropium—Insomnia—Fluorouracil—pancreatic cancer	0.000839	0.00156	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000836	0.00156	CcSEcCtD
Tiotropium—Paraesthesia—Fluorouracil—pancreatic cancer	0.000833	0.00155	CcSEcCtD
Tiotropium—Pruritus—Sunitinib—pancreatic cancer	0.000832	0.00155	CcSEcCtD
Tiotropium—Constipation—Irinotecan—pancreatic cancer	0.000828	0.00154	CcSEcCtD
Tiotropium—Mental disorder—Docetaxel—pancreatic cancer	0.000826	0.00154	CcSEcCtD
Tiotropium—Malnutrition—Docetaxel—pancreatic cancer	0.00082	0.00153	CcSEcCtD
Tiotropium—Dyspepsia—Fluorouracil—pancreatic cancer	0.000816	0.00152	CcSEcCtD
Tiotropium—Nausea—Tamoxifen—pancreatic cancer	0.000815	0.00152	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000814	0.00152	CcSEcCtD
Tiotropium—Constipation—Gemcitabine—pancreatic cancer	0.000807	0.0015	CcSEcCtD
Tiotropium—Nausea—Erlotinib—pancreatic cancer	0.000807	0.0015	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000801	0.00149	CcSEcCtD
Tiotropium—Dysphagia—Epirubicin—pancreatic cancer	0.000794	0.00148	CcSEcCtD
Tiotropium—Back pain—Docetaxel—pancreatic cancer	0.000793	0.00148	CcSEcCtD
Tiotropium—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000792	0.00147	CcSEcCtD
Tiotropium—Dehydration—Doxorubicin—pancreatic cancer	0.000791	0.00147	CcSEcCtD
Tiotropium—Dry skin—Doxorubicin—pancreatic cancer	0.000779	0.00145	CcSEcCtD
Tiotropium—Dizziness—Sunitinib—pancreatic cancer	0.000777	0.00145	CcSEcCtD
Tiotropium—Angina pectoris—Epirubicin—pancreatic cancer	0.000773	0.00144	CcSEcCtD
Tiotropium—Abdominal pain—Irinotecan—pancreatic cancer	0.000766	0.00143	CcSEcCtD
Tiotropium—Vomiting—Sunitinib—pancreatic cancer	0.000748	0.00139	CcSEcCtD
Tiotropium—Dysuria—Epirubicin—pancreatic cancer	0.000743	0.00138	CcSEcCtD
Tiotropium—Rash—Sunitinib—pancreatic cancer	0.000741	0.00138	CcSEcCtD
Tiotropium—Dermatitis—Sunitinib—pancreatic cancer	0.000741	0.00138	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000738	0.00137	CcSEcCtD
Tiotropium—Urticaria—Fluorouracil—pancreatic cancer	0.000737	0.00137	CcSEcCtD
Tiotropium—Headache—Sunitinib—pancreatic cancer	0.000737	0.00137	CcSEcCtD
Tiotropium—Syncope—Docetaxel—pancreatic cancer	0.000736	0.00137	CcSEcCtD
Tiotropium—Dysphagia—Doxorubicin—pancreatic cancer	0.000735	0.00137	CcSEcCtD
Tiotropium—Palpitations—Docetaxel—pancreatic cancer	0.000725	0.00135	CcSEcCtD
Tiotropium—Loss of consciousness—Docetaxel—pancreatic cancer	0.000721	0.00134	CcSEcCtD
Tiotropium—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000716	0.00133	CcSEcCtD
Tiotropium—Cough—Docetaxel—pancreatic cancer	0.000716	0.00133	CcSEcCtD
Tiotropium—Angina pectoris—Doxorubicin—pancreatic cancer	0.000716	0.00133	CcSEcCtD
Tiotropium—Hypersensitivity—Irinotecan—pancreatic cancer	0.000714	0.00133	CcSEcCtD
Tiotropium—Hypertension—Docetaxel—pancreatic cancer	0.000708	0.00132	CcSEcCtD
Tiotropium—Chest pain—Docetaxel—pancreatic cancer	0.000698	0.0013	CcSEcCtD
Tiotropium—Myalgia—Docetaxel—pancreatic cancer	0.000698	0.0013	CcSEcCtD
Tiotropium—Arthralgia—Docetaxel—pancreatic cancer	0.000698	0.0013	CcSEcCtD
Tiotropium—Nausea—Sunitinib—pancreatic cancer	0.000698	0.0013	CcSEcCtD
Tiotropium—Renal failure—Epirubicin—pancreatic cancer	0.000696	0.0013	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000694	0.00129	CcSEcCtD
Tiotropium—Stomatitis—Epirubicin—pancreatic cancer	0.00069	0.00129	CcSEcCtD
Tiotropium—Urinary tract infection—Epirubicin—pancreatic cancer	0.000688	0.00128	CcSEcCtD
Tiotropium—Dysuria—Doxorubicin—pancreatic cancer	0.000687	0.00128	CcSEcCtD
Tiotropium—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000683	0.00127	CcSEcCtD
Tiotropium—Dry mouth—Docetaxel—pancreatic cancer	0.000683	0.00127	CcSEcCtD
Tiotropium—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000683	0.00127	CcSEcCtD
Tiotropium—Oedema—Docetaxel—pancreatic cancer	0.000669	0.00125	CcSEcCtD
Tiotropium—Epistaxis—Epirubicin—pancreatic cancer	0.000668	0.00124	CcSEcCtD
Tiotropium—Pruritus—Gemcitabine—pancreatic cancer	0.000667	0.00124	CcSEcCtD
Tiotropium—Infection—Docetaxel—pancreatic cancer	0.000665	0.00124	CcSEcCtD
Tiotropium—Sinusitis—Epirubicin—pancreatic cancer	0.000664	0.00124	CcSEcCtD
Tiotropium—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000663	0.00123	CcSEcCtD
Tiotropium—Shock—Docetaxel—pancreatic cancer	0.000659	0.00123	CcSEcCtD
Tiotropium—Nervous system disorder—Docetaxel—pancreatic cancer	0.000657	0.00122	CcSEcCtD
Tiotropium—Pruritus—Fluorouracil—pancreatic cancer	0.000656	0.00122	CcSEcCtD
Tiotropium—Tachycardia—Docetaxel—pancreatic cancer	0.000653	0.00122	CcSEcCtD
Tiotropium—Skin disorder—Docetaxel—pancreatic cancer	0.00065	0.00121	CcSEcCtD
Tiotropium—Renal failure—Doxorubicin—pancreatic cancer	0.000644	0.0012	CcSEcCtD
Tiotropium—Dizziness—Irinotecan—pancreatic cancer	0.00064	0.00119	CcSEcCtD
Tiotropium—Stomatitis—Doxorubicin—pancreatic cancer	0.000639	0.00119	CcSEcCtD
Tiotropium—Rhinitis—Epirubicin—pancreatic cancer	0.000637	0.00119	CcSEcCtD
Tiotropium—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000637	0.00119	CcSEcCtD
Tiotropium—Pharyngitis—Epirubicin—pancreatic cancer	0.000631	0.00117	CcSEcCtD
Tiotropium—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000628	0.00117	CcSEcCtD
Tiotropium—Oedema peripheral—Epirubicin—pancreatic cancer	0.000626	0.00117	CcSEcCtD
Tiotropium—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000625	0.00116	CcSEcCtD
Tiotropium—Urethral disorder—Epirubicin—pancreatic cancer	0.000623	0.00116	CcSEcCtD
Tiotropium—Epistaxis—Doxorubicin—pancreatic cancer	0.000618	0.00115	CcSEcCtD
Tiotropium—Vomiting—Irinotecan—pancreatic cancer	0.000616	0.00115	CcSEcCtD
Tiotropium—Sinusitis—Doxorubicin—pancreatic cancer	0.000615	0.00114	CcSEcCtD
Tiotropium—Dizziness—Fluorouracil—pancreatic cancer	0.000613	0.00114	CcSEcCtD
Tiotropium—Visual impairment—Epirubicin—pancreatic cancer	0.000612	0.00114	CcSEcCtD
Tiotropium—Rash—Irinotecan—pancreatic cancer	0.000611	0.00114	CcSEcCtD
Tiotropium—Dermatitis—Irinotecan—pancreatic cancer	0.00061	0.00114	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00061	0.00114	CcSEcCtD
Tiotropium—Headache—Irinotecan—pancreatic cancer	0.000607	0.00113	CcSEcCtD
Tiotropium—Insomnia—Docetaxel—pancreatic cancer	0.000605	0.00113	CcSEcCtD
Tiotropium—Paraesthesia—Docetaxel—pancreatic cancer	0.000601	0.00112	CcSEcCtD
Tiotropium—Vomiting—Gemcitabine—pancreatic cancer	0.0006	0.00112	CcSEcCtD
Tiotropium—Rash—Gemcitabine—pancreatic cancer	0.000595	0.00111	CcSEcCtD
Tiotropium—Dermatitis—Gemcitabine—pancreatic cancer	0.000594	0.00111	CcSEcCtD
Tiotropium—Eye disorder—Epirubicin—pancreatic cancer	0.000594	0.00111	CcSEcCtD
Tiotropium—Headache—Gemcitabine—pancreatic cancer	0.000591	0.0011	CcSEcCtD
Tiotropium—Vomiting—Fluorouracil—pancreatic cancer	0.00059	0.0011	CcSEcCtD
Tiotropium—Rhinitis—Doxorubicin—pancreatic cancer	0.00059	0.0011	CcSEcCtD
Tiotropium—Dyspepsia—Docetaxel—pancreatic cancer	0.000589	0.0011	CcSEcCtD
Tiotropium—Rash—Fluorouracil—pancreatic cancer	0.000585	0.00109	CcSEcCtD
Tiotropium—Dermatitis—Fluorouracil—pancreatic cancer	0.000584	0.00109	CcSEcCtD
Tiotropium—Pharyngitis—Doxorubicin—pancreatic cancer	0.000584	0.00109	CcSEcCtD
Tiotropium—Headache—Fluorouracil—pancreatic cancer	0.000581	0.00108	CcSEcCtD
Tiotropium—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000581	0.00108	CcSEcCtD
Tiotropium—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000579	0.00108	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000578	0.00108	CcSEcCtD
Tiotropium—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000578	0.00108	CcSEcCtD
Tiotropium—Angiopathy—Epirubicin—pancreatic cancer	0.000577	0.00107	CcSEcCtD
Tiotropium—Urethral disorder—Doxorubicin—pancreatic cancer	0.000576	0.00107	CcSEcCtD
Tiotropium—Nausea—Irinotecan—pancreatic cancer	0.000575	0.00107	CcSEcCtD
Tiotropium—Immune system disorder—Epirubicin—pancreatic cancer	0.000574	0.00107	CcSEcCtD
Tiotropium—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000573	0.00107	CcSEcCtD
Tiotropium—Constipation—Docetaxel—pancreatic cancer	0.000572	0.00107	CcSEcCtD
Tiotropium—Arrhythmia—Epirubicin—pancreatic cancer	0.000568	0.00106	CcSEcCtD
Tiotropium—Visual impairment—Doxorubicin—pancreatic cancer	0.000567	0.00106	CcSEcCtD
Tiotropium—Nausea—Gemcitabine—pancreatic cancer	0.00056	0.00104	CcSEcCtD
Tiotropium—Mental disorder—Epirubicin—pancreatic cancer	0.000557	0.00104	CcSEcCtD
Tiotropium—Malnutrition—Epirubicin—pancreatic cancer	0.000553	0.00103	CcSEcCtD
Tiotropium—Nausea—Fluorouracil—pancreatic cancer	0.000551	0.00103	CcSEcCtD
Tiotropium—Eye disorder—Doxorubicin—pancreatic cancer	0.00055	0.00102	CcSEcCtD
Tiotropium—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000547	0.00102	CcSEcCtD
Tiotropium—Back pain—Epirubicin—pancreatic cancer	0.000535	0.000997	CcSEcCtD
Tiotropium—Angiopathy—Doxorubicin—pancreatic cancer	0.000534	0.000994	CcSEcCtD
Tiotropium—Immune system disorder—Doxorubicin—pancreatic cancer	0.000531	0.000989	CcSEcCtD
Tiotropium—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.00053	0.000987	CcSEcCtD
Tiotropium—Abdominal pain—Docetaxel—pancreatic cancer	0.000529	0.000985	CcSEcCtD
Tiotropium—Arrhythmia—Doxorubicin—pancreatic cancer	0.000525	0.000978	CcSEcCtD
Tiotropium—Vision blurred—Epirubicin—pancreatic cancer	0.000521	0.000971	CcSEcCtD
Tiotropium—Mental disorder—Doxorubicin—pancreatic cancer	0.000515	0.000959	CcSEcCtD
Tiotropium—Malnutrition—Doxorubicin—pancreatic cancer	0.000512	0.000953	CcSEcCtD
Tiotropium—Syncope—Epirubicin—pancreatic cancer	0.000496	0.000924	CcSEcCtD
Tiotropium—Back pain—Doxorubicin—pancreatic cancer	0.000495	0.000922	CcSEcCtD
Tiotropium—Hypersensitivity—Docetaxel—pancreatic cancer	0.000493	0.000918	CcSEcCtD
Tiotropium—Palpitations—Epirubicin—pancreatic cancer	0.000489	0.00091	CcSEcCtD
Tiotropium—Loss of consciousness—Epirubicin—pancreatic cancer	0.000486	0.000905	CcSEcCtD
Tiotropium—Cough—Epirubicin—pancreatic cancer	0.000483	0.000899	CcSEcCtD
Tiotropium—Vision blurred—Doxorubicin—pancreatic cancer	0.000482	0.000898	CcSEcCtD
Tiotropium—Hypertension—Epirubicin—pancreatic cancer	0.000478	0.000889	CcSEcCtD
Tiotropium—Pruritus—Docetaxel—pancreatic cancer	0.000474	0.000882	CcSEcCtD
Tiotropium—Myalgia—Epirubicin—pancreatic cancer	0.000471	0.000877	CcSEcCtD
Tiotropium—Chest pain—Epirubicin—pancreatic cancer	0.000471	0.000877	CcSEcCtD
Tiotropium—Arthralgia—Epirubicin—pancreatic cancer	0.000471	0.000877	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000468	0.000871	CcSEcCtD
Tiotropium—Dry mouth—Epirubicin—pancreatic cancer	0.000461	0.000858	CcSEcCtD
Tiotropium—Syncope—Doxorubicin—pancreatic cancer	0.000459	0.000855	CcSEcCtD
Tiotropium—Palpitations—Doxorubicin—pancreatic cancer	0.000452	0.000842	CcSEcCtD
Tiotropium—Oedema—Epirubicin—pancreatic cancer	0.000452	0.000841	CcSEcCtD
Tiotropium—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00045	0.000838	CcSEcCtD
Tiotropium—Infection—Epirubicin—pancreatic cancer	0.000449	0.000835	CcSEcCtD
Tiotropium—Cough—Doxorubicin—pancreatic cancer	0.000447	0.000832	CcSEcCtD
Tiotropium—Shock—Epirubicin—pancreatic cancer	0.000444	0.000827	CcSEcCtD
Tiotropium—Nervous system disorder—Epirubicin—pancreatic cancer	0.000443	0.000825	CcSEcCtD
Tiotropium—Dizziness—Docetaxel—pancreatic cancer	0.000443	0.000824	CcSEcCtD
Tiotropium—Hypertension—Doxorubicin—pancreatic cancer	0.000442	0.000823	CcSEcCtD
Tiotropium—Tachycardia—Epirubicin—pancreatic cancer	0.000441	0.000821	CcSEcCtD
Tiotropium—Skin disorder—Epirubicin—pancreatic cancer	0.000439	0.000817	CcSEcCtD
Tiotropium—Myalgia—Doxorubicin—pancreatic cancer	0.000436	0.000812	CcSEcCtD
Tiotropium—Chest pain—Doxorubicin—pancreatic cancer	0.000436	0.000812	CcSEcCtD
Tiotropium—Arthralgia—Doxorubicin—pancreatic cancer	0.000436	0.000812	CcSEcCtD
Tiotropium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000433	0.000806	CcSEcCtD
Tiotropium—Dry mouth—Doxorubicin—pancreatic cancer	0.000426	0.000794	CcSEcCtD
Tiotropium—Vomiting—Docetaxel—pancreatic cancer	0.000426	0.000793	CcSEcCtD
Tiotropium—Rash—Docetaxel—pancreatic cancer	0.000422	0.000786	CcSEcCtD
Tiotropium—Dermatitis—Docetaxel—pancreatic cancer	0.000422	0.000785	CcSEcCtD
Tiotropium—Headache—Docetaxel—pancreatic cancer	0.000419	0.000781	CcSEcCtD
Tiotropium—Oedema—Doxorubicin—pancreatic cancer	0.000418	0.000778	CcSEcCtD
Tiotropium—Infection—Doxorubicin—pancreatic cancer	0.000415	0.000773	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000411	0.000766	CcSEcCtD
Tiotropium—Shock—Doxorubicin—pancreatic cancer	0.000411	0.000765	CcSEcCtD
Tiotropium—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00041	0.000763	CcSEcCtD
Tiotropium—Insomnia—Epirubicin—pancreatic cancer	0.000408	0.00076	CcSEcCtD
Tiotropium—Tachycardia—Doxorubicin—pancreatic cancer	0.000408	0.000759	CcSEcCtD
Tiotropium—Skin disorder—Doxorubicin—pancreatic cancer	0.000406	0.000756	CcSEcCtD
Tiotropium—Paraesthesia—Epirubicin—pancreatic cancer	0.000405	0.000755	CcSEcCtD
Tiotropium—Nausea—Docetaxel—pancreatic cancer	0.000398	0.00074	CcSEcCtD
Tiotropium—Dyspepsia—Epirubicin—pancreatic cancer	0.000397	0.00074	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.00039	0.000726	CcSEcCtD
Tiotropium—Constipation—Epirubicin—pancreatic cancer	0.000386	0.000719	CcSEcCtD
Tiotropium—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000381	0.000709	CcSEcCtD
Tiotropium—Insomnia—Doxorubicin—pancreatic cancer	0.000378	0.000704	CcSEcCtD
Tiotropium—Paraesthesia—Doxorubicin—pancreatic cancer	0.000375	0.000699	CcSEcCtD
Tiotropium—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000369	0.000688	CcSEcCtD
Tiotropium—Dyspepsia—Doxorubicin—pancreatic cancer	0.000368	0.000685	CcSEcCtD
Tiotropium—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000361	0.000672	CcSEcCtD
Tiotropium—Urticaria—Epirubicin—pancreatic cancer	0.000359	0.000668	CcSEcCtD
Tiotropium—Constipation—Doxorubicin—pancreatic cancer	0.000357	0.000665	CcSEcCtD
Tiotropium—Abdominal pain—Epirubicin—pancreatic cancer	0.000357	0.000665	CcSEcCtD
Tiotropium—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000342	0.000636	CcSEcCtD
Tiotropium—Hypersensitivity—Epirubicin—pancreatic cancer	0.000333	0.000619	CcSEcCtD
Tiotropium—Urticaria—Doxorubicin—pancreatic cancer	0.000332	0.000618	CcSEcCtD
Tiotropium—Abdominal pain—Doxorubicin—pancreatic cancer	0.00033	0.000615	CcSEcCtD
Tiotropium—Pruritus—Epirubicin—pancreatic cancer	0.000319	0.000595	CcSEcCtD
Tiotropium—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000308	0.000573	CcSEcCtD
Tiotropium—Dizziness—Epirubicin—pancreatic cancer	0.000299	0.000556	CcSEcCtD
Tiotropium—Pruritus—Doxorubicin—pancreatic cancer	0.000296	0.00055	CcSEcCtD
Tiotropium—Vomiting—Epirubicin—pancreatic cancer	0.000287	0.000535	CcSEcCtD
Tiotropium—Rash—Epirubicin—pancreatic cancer	0.000285	0.00053	CcSEcCtD
Tiotropium—Dermatitis—Epirubicin—pancreatic cancer	0.000284	0.00053	CcSEcCtD
Tiotropium—Headache—Epirubicin—pancreatic cancer	0.000283	0.000527	CcSEcCtD
Tiotropium—Dizziness—Doxorubicin—pancreatic cancer	0.000276	0.000514	CcSEcCtD
Tiotropium—Nausea—Epirubicin—pancreatic cancer	0.000268	0.000499	CcSEcCtD
Tiotropium—Vomiting—Doxorubicin—pancreatic cancer	0.000266	0.000495	CcSEcCtD
Tiotropium—Rash—Doxorubicin—pancreatic cancer	0.000263	0.000491	CcSEcCtD
Tiotropium—Dermatitis—Doxorubicin—pancreatic cancer	0.000263	0.00049	CcSEcCtD
Tiotropium—Headache—Doxorubicin—pancreatic cancer	0.000262	0.000487	CcSEcCtD
Tiotropium—Nausea—Doxorubicin—pancreatic cancer	0.000248	0.000462	CcSEcCtD
Tiotropium—CHRM5—Signaling Pathways—SMAD4—pancreatic cancer	5.86e-05	0.000307	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—CXCL8—pancreatic cancer	5.79e-05	0.000304	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HES1—pancreatic cancer	5.72e-05	0.0003	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SST—pancreatic cancer	5.62e-05	0.000294	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—STK11—pancreatic cancer	5.61e-05	0.000294	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SST—pancreatic cancer	5.6e-05	0.000293	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SST—pancreatic cancer	5.55e-05	0.000291	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.54e-05	0.00029	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.52e-05	0.000289	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.51e-05	0.000289	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	5.5e-05	0.000288	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	5.48e-05	0.000287	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PIK3CB—pancreatic cancer	5.48e-05	0.000287	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	5.47e-05	0.000287	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.47e-05	0.000287	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	5.46e-05	0.000286	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	5.43e-05	0.000284	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	5.4e-05	0.000283	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—CXCL8—pancreatic cancer	5.26e-05	0.000276	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	5.18e-05	0.000272	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	5.17e-05	0.000271	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GLP1R—pancreatic cancer	5.15e-05	0.00027	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	5.12e-05	0.000268	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—DPYD—pancreatic cancer	5.07e-05	0.000265	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	5.03e-05	0.000264	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	5.02e-05	0.000263	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TERT—pancreatic cancer	5.01e-05	0.000263	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GCG—pancreatic cancer	5.01e-05	0.000262	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GCG—pancreatic cancer	4.99e-05	0.000262	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	4.97e-05	0.00026	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GCG—pancreatic cancer	4.94e-05	0.000259	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.87e-05	0.000255	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.86e-05	0.000254	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—TYMS—pancreatic cancer	4.83e-05	0.000253	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.81e-05	0.000252	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	4.81e-05	0.000252	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	4.79e-05	0.000251	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	4.78e-05	0.00025	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.78e-05	0.00025	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	4.78e-05	0.00025	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	4.76e-05	0.000249	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	4.71e-05	0.000247	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—STK11—pancreatic cancer	4.71e-05	0.000247	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—STK11—pancreatic cancer	4.69e-05	0.000246	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—APOE—pancreatic cancer	4.68e-05	0.000245	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—STK11—pancreatic cancer	4.65e-05	0.000243	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KDR—pancreatic cancer	4.58e-05	0.00024	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	4.42e-05	0.000232	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	4.41e-05	0.000231	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.37e-05	0.000229	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	4.36e-05	0.000228	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	4.32e-05	0.000226	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.25e-05	0.000222	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.23e-05	0.000222	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	4.22e-05	0.000221	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	4.22e-05	0.000221	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.19e-05	0.00022	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.18e-05	0.000219	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EGF—pancreatic cancer	4.17e-05	0.000219	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	4.12e-05	0.000216	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	4.11e-05	0.000215	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.08e-05	0.000214	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	4.07e-05	0.000213	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	4.07e-05	0.000213	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.03e-05	0.000211	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HES1—pancreatic cancer	4.03e-05	0.000211	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HES1—pancreatic cancer	4.01e-05	0.00021	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HES1—pancreatic cancer	3.97e-05	0.000208	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—APOE—pancreatic cancer	3.93e-05	0.000206	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	3.86e-05	0.000202	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	3.85e-05	0.000202	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	3.84e-05	0.000201	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	3.81e-05	0.000199	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CD44—pancreatic cancer	3.72e-05	0.000195	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	3.71e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	3.7e-05	0.000194	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	3.69e-05	0.000193	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.68e-05	0.000193	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	3.66e-05	0.000192	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	3.63e-05	0.00019	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—GCG—pancreatic cancer	3.57e-05	0.000187	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CG—pancreatic cancer	3.54e-05	0.000186	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TERT—pancreatic cancer	3.53e-05	0.000185	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TERT—pancreatic cancer	3.52e-05	0.000184	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TERT—pancreatic cancer	3.48e-05	0.000182	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PPARG—pancreatic cancer	3.42e-05	0.000179	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	3.37e-05	0.000177	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.37e-05	0.000176	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	3.37e-05	0.000176	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	3.36e-05	0.000176	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—STK11—pancreatic cancer	3.36e-05	0.000176	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	3.35e-05	0.000176	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	3.34e-05	0.000175	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	3.33e-05	0.000174	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	3.32e-05	0.000174	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.31e-05	0.000174	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—APOE—pancreatic cancer	3.29e-05	0.000173	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—APOE—pancreatic cancer	3.28e-05	0.000172	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—APOE—pancreatic cancer	3.25e-05	0.00017	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	3.23e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KDR—pancreatic cancer	3.23e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KDR—pancreatic cancer	3.22e-05	0.000169	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KDR—pancreatic cancer	3.18e-05	0.000167	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.14e-05	0.000165	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CD—pancreatic cancer	3.11e-05	0.000163	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	3.11e-05	0.000163	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	3.09e-05	0.000162	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	3.07e-05	0.000161	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	3.06e-05	0.00016	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	3.04e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	3.03e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	3.03e-05	0.000159	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	3e-05	0.000157	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	3e-05	0.000157	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	2.97e-05	0.000156	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	2.97e-05	0.000156	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	2.97e-05	0.000156	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	2.96e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	2.96e-05	0.000155	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EGF—pancreatic cancer	2.94e-05	0.000154	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	2.93e-05	0.000154	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	2.93e-05	0.000154	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EGF—pancreatic cancer	2.93e-05	0.000153	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EGF—pancreatic cancer	2.9e-05	0.000152	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	2.9e-05	0.000152	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—TYMS—pancreatic cancer	2.89e-05	0.000151	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	2.87e-05	0.00015	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	2.81e-05	0.000147	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	2.79e-05	0.000146	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	2.73e-05	0.000143	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CB—pancreatic cancer	2.71e-05	0.000142	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	2.71e-05	0.000142	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	2.7e-05	0.000141	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTGS2—pancreatic cancer	2.69e-05	0.000141	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	2.67e-05	0.00014	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	2.61e-05	0.000137	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	2.6e-05	0.000136	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—SRC—pancreatic cancer	2.59e-05	0.000136	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.59e-05	0.000136	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.58e-05	0.000135	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	2.58e-05	0.000135	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	2.56e-05	0.000134	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.55e-05	0.000134	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	2.55e-05	0.000134	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	2.53e-05	0.000132	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	2.52e-05	0.000132	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	2.5e-05	0.000131	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	2.49e-05	0.000131	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CD44—pancreatic cancer	2.43e-05	0.000128	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.35e-05	0.000123	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—APOE—pancreatic cancer	2.35e-05	0.000123	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PTEN—pancreatic cancer	2.35e-05	0.000123	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	2.34e-05	0.000123	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—GCG—pancreatic cancer	2.33e-05	0.000122	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—MYC—pancreatic cancer	2.32e-05	0.000122	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.32e-05	0.000122	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	2.32e-05	0.000121	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	2.28e-05	0.000119	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	2.27e-05	0.000119	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	2.27e-05	0.000119	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	2.25e-05	0.000118	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—STK11—pancreatic cancer	2.19e-05	0.000115	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	2.19e-05	0.000115	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	2.18e-05	0.000114	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	2.17e-05	0.000114	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	2.17e-05	0.000114	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	2.16e-05	0.000113	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	2.15e-05	0.000112	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	2.15e-05	0.000112	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	2.12e-05	0.000111	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	2.11e-05	0.000111	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	2.11e-05	0.00011	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	2.09e-05	0.00011	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	2.09e-05	0.000109	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	2.09e-05	0.000109	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	2.07e-05	0.000108	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PPARG—pancreatic cancer	2.04e-05	0.000107	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	2.04e-05	0.000107	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	2.03e-05	0.000106	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.02e-05	0.000106	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	2.01e-05	0.000105	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.01e-05	0.000105	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	1.99e-05	0.000104	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	1.98e-05	0.000104	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	1.97e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	1.97e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	1.97e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	1.96e-05	0.000103	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	1.95e-05	0.000102	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	1.94e-05	0.000102	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	1.92e-05	0.000101	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	1.91e-05	0.0001	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—TP53—pancreatic cancer	1.91e-05	9.99e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	1.9e-05	9.93e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.89e-05	9.89e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	1.86e-05	9.76e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—SRC—pancreatic cancer	1.82e-05	9.56e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	1.82e-05	9.56e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—SRC—pancreatic cancer	1.82e-05	9.53e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—SRC—pancreatic cancer	1.8e-05	9.44e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	1.78e-05	9.31e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	1.77e-05	9.28e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	1.76e-05	9.22e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	1.76e-05	9.2e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	1.75e-05	9.19e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	1.75e-05	9.19e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	1.75e-05	9.17e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.74e-05	9.1e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.73e-05	9.08e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—PIK3CA—pancreatic cancer	1.66e-05	8.67e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—MYC—pancreatic cancer	1.64e-05	8.57e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.63e-05	8.55e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—MYC—pancreatic cancer	1.63e-05	8.54e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	1.63e-05	8.52e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	1.62e-05	8.51e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.61e-05	8.46e-05	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	1.61e-05	8.44e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.61e-05	8.44e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTGS2—pancreatic cancer	1.61e-05	8.43e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	1.6e-05	8.38e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	1.59e-05	8.35e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.58e-05	8.27e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—APOE—pancreatic cancer	1.53e-05	8.04e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	1.51e-05	7.92e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	1.51e-05	7.89e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.49e-05	7.82e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PTEN—pancreatic cancer	1.4e-05	7.35e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.39e-05	7.27e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.39e-05	7.26e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.38e-05	7.25e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.37e-05	7.18e-05	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—AKT1—pancreatic cancer	1.35e-05	7.08e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—TP53—pancreatic cancer	1.34e-05	7.04e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—TP53—pancreatic cancer	1.34e-05	7.01e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.34e-05	7e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.33e-05	6.95e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	1.28e-05	6.73e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	1.28e-05	6.71e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.27e-05	6.64e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.22e-05	6.38e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.13e-05	5.94e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.13e-05	5.92e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.12e-05	5.87e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.06e-05	5.56e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.05e-05	5.51e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	9.9e-06	5.19e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PTEN—pancreatic cancer	9.17e-06	4.81e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—AKT1—pancreatic cancer	8.08e-06	4.24e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.47e-06	3.39e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.29e-06	2.77e-05	CbGpPWpGaD
